122 related articles for article (PubMed ID: 12866729)
1. Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.
Tatarczyńska E; Pałucha A; Szewczyk B; Chojnacka-Wójcik E; Wierońska J; Pilc A
Pol J Pharmacol; 2002; 54(6):707-10. PubMed ID: 12866729
[TBL] [Abstract][Full Text] [Related]
2. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
3. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
4. The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration.
Tatarczyńska E; Kłodzińska A; Kroczka B; Chojnacka-Wójcik E; Pilc A
Psychopharmacology (Berl); 2001 Oct; 158(1):94-9. PubMed ID: 11685389
[TBL] [Abstract][Full Text] [Related]
5. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
[TBL] [Abstract][Full Text] [Related]
6. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.
Pałucha A; Tatarczyńska E; Brański P; Szewczyk B; Wierońska JM; Kłak K; Chojnacka-Wójcik E; Nowak G; Pilc A
Neuropharmacology; 2004 Feb; 46(2):151-9. PubMed ID: 14680755
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Pharmacol Rep; 2006; 58(6):820-6. PubMed ID: 17220539
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
Chapman AG; Talebi A; Yip PK; Meldrum BS
Eur J Pharmacol; 2001 Jul; 424(2):107-13. PubMed ID: 11476756
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic action of group II and III metabotropic glutamate receptors agonists involves neuropeptide Y in the amygdala.
Wierońska JM; Szewczyk B; Pałucha A; Brański P; Zieba B; Smiałowska M
Pharmacol Rep; 2005; 57(6):734-43. PubMed ID: 16382191
[TBL] [Abstract][Full Text] [Related]
10. Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice.
Pałucha-Poniewiera A; Novák K; Pilc A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1454-7. PubMed ID: 19660510
[TBL] [Abstract][Full Text] [Related]
11. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective potential of the group III mGlu receptor agonist ACPT-I in animal models of ischemic stroke: In vitro and in vivo studies.
Domin H; Przykaza Ł; Jantas D; Kozniewska E; Boguszewski PM; Śmiałowska M
Neuropharmacology; 2016 Mar; 102():276-94. PubMed ID: 26647070
[TBL] [Abstract][Full Text] [Related]
13. Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.
Kłak K; Pałucha A; Brański P; Sowa M; Pilc A
Amino Acids; 2007 Feb; 32(2):169-72. PubMed ID: 16868652
[TBL] [Abstract][Full Text] [Related]
14. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
Howson PA; Jane DE
Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.
Acher FC; Tellier FJ; Azerad R; Brabet IN; Fagni L; Pin JP
J Med Chem; 1997 Sep; 40(19):3119-29. PubMed ID: 9301676
[TBL] [Abstract][Full Text] [Related]
16. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
Domin H; Gołembiowska K; Jantas D; Kamińska K; Zięba B; Smiałowska M
Neurotox Res; 2014 Jul; 26(1):99-113. PubMed ID: 24402869
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like effects of metabotropic glutamate antagonist (RS)-alpha-methylserine-O-phosphate in rats.
Chojnacka-Wójcik E; Tatarczyńska E; Pilc A
Pol J Pharmacol; 1996; 48(5):507-9. PubMed ID: 9112693
[TBL] [Abstract][Full Text] [Related]
19. Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
Lopez S; Jouve L; Turle-Lorenzo N; Kerkerian-Legoff L; Salin P; Amalric M
Neurobiol Dis; 2012 Apr; 46(1):69-77. PubMed ID: 22245662
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
